Selected research
Market Structure
Global Animal-derived Immune Globulin Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Animal-derived Immune Globulin Products market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Animal-derived Immune Globulin Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Animal-derived Immune Globulin Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Animal-derived Immune Globulin Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Animal-derived Immune Globulin Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Animal-derived Immune Globulin Products include Sanofi, Merck & Co, Pfizer, Rare Disease Therapeutics, BTG Specialty Pharmaceuticals and Bioclon Institute, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Animal-derived Immune Globulin Products market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Animal-derived Immune Globulin Products and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Animal-derived Immune Globulin Products sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Animal-derived Immune Globulin Products market size, projected growth trends, production technologies, key applications, and end-use industries.
Animal-derived Immune Globulin Products Segment by Company
Sanofi
Merck & Co
Pfizer
Rare Disease Therapeutics
BTG Specialty Pharmaceuticals
Bioclon Institute
Animal-derived Immune Globulin Products Segment by Type
IVIg Liquid
IVIg Powder
Animal-derived Immune Globulin Products Segment by Application
Autoimmune Disease
Immunodeficiency
Acute Infection
Animal-derived Immune Globulin Products Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal-derived Immune Globulin Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Animal-derived Immune Globulin Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal-derived Immune Globulin Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Animal-derived Immune Globulin Products market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Animal-derived Immune Globulin Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Animal-derived Immune Globulin Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Animal-derived Immune Globulin Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- IVIg Liquid
- IVIg Powder
Applications
- Autoimmune Disease
- Immunodeficiency
- Acute Infection
Companies covered
- Sanofi
- Merck & Co
- Pfizer
- Rare Disease Therapeutics
- BTG Specialty Pharmaceuticals
- Bioclon Institute
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Animal-derived Immune Globulin Products Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Animal-derived Immune Globulin Products Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Animal-derived Immune Globulin Products Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Animal-derived Immune Globulin Products Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Animal-derived Immune Globulin Products Market Dynamics
- 2.1 Animal-derived Immune Globulin Products Industry Trends
- 2.2 Animal-derived Immune Globulin Products Industry Drivers
- 2.3 Animal-derived Immune Globulin Products Industry Opportunities and Challenges
- 2.4 Animal-derived Immune Globulin Products Industry Restraints
3 Animal-derived Immune Globulin Products Market by Manufacturers
- 3.1 Global Animal-derived Immune Globulin Products Revenue by Manufacturers (2021-2026)
- 3.2 Global Animal-derived Immune Globulin Products Sales by Manufacturers (2021-2026)
- 3.3 Global Animal-derived Immune Globulin Products Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Animal-derived Immune Globulin Products Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Animal-derived Immune Globulin Products Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Animal-derived Immune Globulin Products Manufacturers, Product Type & Application
- 3.7 Global Animal-derived Immune Globulin Products Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Animal-derived Immune Globulin Products Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Animal-derived Immune Globulin Products Players Market Share by Revenue in 2025
- 3.8.3 2025 Animal-derived Immune Globulin Products Tier 1, Tier 2, and Tier 3
4 Animal-derived Immune Globulin Products Market by Type
- 4.1 Animal-derived Immune Globulin Products Type Introduction
- 4.1.1 IVIg Liquid
- 4.1.2 IVIg Powder
- 4.2 Global Animal-derived Immune Globulin Products Sales by Type
- 4.2.1 Global Animal-derived Immune Globulin Products Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Animal-derived Immune Globulin Products Sales by Type (2021-2032)
- 4.2.3 Global Animal-derived Immune Globulin Products Sales Market Share by Type (2021-2032)
- 4.3 Global Animal-derived Immune Globulin Products Revenue by Type
- 4.3.1 Global Animal-derived Immune Globulin Products Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Animal-derived Immune Globulin Products Revenue by Type (2021-2032)
- 4.3.3 Global Animal-derived Immune Globulin Products Revenue Market Share by Type (2021-2032)
5 Animal-derived Immune Globulin Products Market by Application
- 5.1 Animal-derived Immune Globulin Products Application Introduction
- 5.1.1 Autoimmune Disease
- 5.1.2 Immunodeficiency
- 5.1.3 Acute Infection
- 5.2 Global Animal-derived Immune Globulin Products Sales by Application
- 5.2.1 Global Animal-derived Immune Globulin Products Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Animal-derived Immune Globulin Products Sales by Application (2021-2032)
- 5.2.3 Global Animal-derived Immune Globulin Products Sales Market Share by Application (2021-2032)
- 5.3 Global Animal-derived Immune Globulin Products Revenue by Application
- 5.3.1 Global Animal-derived Immune Globulin Products Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Animal-derived Immune Globulin Products Revenue by Application (2021-2032)
- 5.3.3 Global Animal-derived Immune Globulin Products Revenue Market Share by Application (2021-2032)
6 Global Animal-derived Immune Globulin Products Sales by Region
- 6.1 Global Animal-derived Immune Globulin Products Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Animal-derived Immune Globulin Products Sales by Region (2021-2032)
- 6.2.1 Global Animal-derived Immune Globulin Products Sales by Region (2021-2026)
- 6.2.2 Global Animal-derived Immune Globulin Products Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Animal-derived Immune Globulin Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Animal-derived Immune Globulin Products Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Animal-derived Immune Globulin Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Animal-derived Immune Globulin Products Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Animal-derived Immune Globulin Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Animal-derived Immune Globulin Products Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Animal-derived Immune Globulin Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Animal-derived Immune Globulin Products Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Animal-derived Immune Globulin Products Revenue by Region
- 7.1 Global Animal-derived Immune Globulin Products Revenue by Region
- 7.1.1 Global Animal-derived Immune Globulin Products Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Animal-derived Immune Globulin Products Revenue by Region (2021-2026)
- 7.1.3 Global Animal-derived Immune Globulin Products Revenue by Region (2027-2032)
- 7.1.4 Global Animal-derived Immune Globulin Products Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Animal-derived Immune Globulin Products Revenue (2021-2032)
- 7.2.2 North America Animal-derived Immune Globulin Products Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Animal-derived Immune Globulin Products Revenue (2021-2032)
- 7.3.2 Europe Animal-derived Immune Globulin Products Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Animal-derived Immune Globulin Products Revenue (2021-2032)
- 7.4.2 Asia-Pacific Animal-derived Immune Globulin Products Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Animal-derived Immune Globulin Products Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Animal-derived Immune Globulin Products Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Sanofi
- 8.1.1 Sanofi Company Information
- 8.1.2 Sanofi Business Overview
- 8.1.3 Sanofi Animal-derived Immune Globulin Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Sanofi Animal-derived Immune Globulin Products Product Portfolio
- 8.1.5 Sanofi Recent Developments
- 8.2 Merck & Co
- 8.2.1 Merck & Co Company Information
- 8.2.2 Merck & Co Business Overview
- 8.2.3 Merck & Co Animal-derived Immune Globulin Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Merck & Co Animal-derived Immune Globulin Products Product Portfolio
- 8.2.5 Merck & Co Recent Developments
- 8.3 Pfizer
- 8.3.1 Pfizer Company Information
- 8.3.2 Pfizer Business Overview
- 8.3.3 Pfizer Animal-derived Immune Globulin Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Pfizer Animal-derived Immune Globulin Products Product Portfolio
- 8.3.5 Pfizer Recent Developments
- 8.4 Rare Disease Therapeutics
- 8.4.1 Rare Disease Therapeutics Company Information
- 8.4.2 Rare Disease Therapeutics Business Overview
- 8.4.3 Rare Disease Therapeutics Animal-derived Immune Globulin Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Rare Disease Therapeutics Animal-derived Immune Globulin Products Product Portfolio
- 8.4.5 Rare Disease Therapeutics Recent Developments
- 8.5 BTG Specialty Pharmaceuticals
- 8.5.1 BTG Specialty Pharmaceuticals Company Information
- 8.5.2 BTG Specialty Pharmaceuticals Business Overview
- 8.5.3 BTG Specialty Pharmaceuticals Animal-derived Immune Globulin Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 BTG Specialty Pharmaceuticals Animal-derived Immune Globulin Products Product Portfolio
- 8.5.5 BTG Specialty Pharmaceuticals Recent Developments
- 8.6 Bioclon Institute
- 8.6.1 Bioclon Institute Company Information
- 8.6.2 Bioclon Institute Business Overview
- 8.6.3 Bioclon Institute Animal-derived Immune Globulin Products Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Bioclon Institute Animal-derived Immune Globulin Products Product Portfolio
- 8.6.5 Bioclon Institute Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Animal-derived Immune Globulin Products Value Chain Analysis
- 9.1.1 Animal-derived Immune Globulin Products Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Animal-derived Immune Globulin Products Production Mode & Process
- 9.2 Animal-derived Immune Globulin Products Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Animal-derived Immune Globulin Products Distributors
- 9.2.3 Animal-derived Immune Globulin Products Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst